PLEGRIDY

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug PLEGRIDY contains one active pharmaceutical ingredient (API):

1 Peginterferon beta-1a UNII I8309403R0 - PEGINTERFERON BETA-1A

Peginterferon beta-1a is an interferon conjugated to a single, linear 20 kDa methoxy poly(ethyleneglycol) molecule at the alpha-amino group of the N-terminal amino acid residue. A definitive mechanism of action of peginterferon beta-1a in multiple sclerosis (MS) is not known. Peginterferon beta-1a binds to the type I interferon receptor on the surface of cells and elicits a cascade of intracellular events leading to the regulation of interferon-responsive gene expression. Read about Peginterferon beta-1a

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PLEGRIDY Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AB13		L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10212L, 10218T, 10220X
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538317050001707, 538317050001807, 538317050001907, 538317050002007
Country: CA	Health Products and Food Branch	Identifier(s): 02444399, 02444402
Country: EE	Ravimiamet	Identifier(s): 1657874, 1657931, 1657942, 1657953, 1657964, 1657975
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114934001, 114934002, 114934003, 114934005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 373251, 522427
Country: FR	Base de données publique des médicaments	Identifier(s): 60665360, 61349130, 66988648, 69002701
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 279523, 279529, 279539, 280183, 393564
Country: IE	Health Products Regulatory Authority	Identifier(s): 88461, 88462, 89061
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7630, 7632
Country: IT	Agenzia del Farmaco	Identifier(s): 043527011, 043527023, 043527035, 043527047, 043527050, 043527062, 043527074, 043527086
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1073915, 1073916, 1073917, 1073918, 1073919, 1073920, 1091574, 1091575
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 125253, 125261, 125288, 125296
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17464, 17466
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100325822, 100325839
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64761001, W65152001, W65152002, W65153001, W65153002, W65154001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10913021H, 10913022H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699783950088, 8699783950095
Country: US	FDA, National Drug Code	Identifier(s): 64406-011, 64406-015
Country: ZA	Health Products Regulatory Authority	Identifier(s): 48/32.16/0426, 48/32.16/0427, 48/32.16/0428